1 2 3 4 5

The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes

Stathopoulos, George P.; Malamos, Nikolaos A.; Markopoulos, Christos; More

Anti-Cancer Drugs . 25(8):950-957, September 2014.

Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group

Pistamaltzian, Nikolaos; Tzannis, Kimon; Pissanidou, Vassiliki; More

Anti-Cancer Drugs . 27(1):48-53, January 2016.

Clinical and histopathological effects of presurgical treatment with sunitinib for renal cell carcinoma with inferior vena cava tumor thrombus at a single institution

Ujike, Takeshi; Uemura, Motohide; Kawashima, Atsunari; More

Anti-Cancer Drugs . 27(10):1038-1043, November 2016.

Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies

Rixe, Olivier; Puzanov, Igor; LoRusso, Patricia M.; More

Anti-Cancer Drugs . 26(7):785-792, August 2015.

Reduced folate and serum vitamin metabolites in patients with rectal carcinoma: an open-label feasibility study of pemetrexed with folic acid and vitamin B12 supplementation

Stoffregen, Clemens C.; Odin, Elisabeth A.; Carlsson, Göran U.; More

Anti-Cancer Drugs . 27(5):439-446, June 2016.

Complete response after rechallenge with trabectedin in a patient with previously responding high-grade undifferentiated sarcoma

Baldi, Giacomo G.; Di Donato, Samantha; Fargnoli, Rossana; More

Anti-Cancer Drugs . 27(9):908-913, October 2016.

Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer

Stahler, Arndt; Heinemann, Volker; Neumann, Jens; More

Anti-Cancer Drugs . 28(7):717-722, August 2017.

Trabectedin in advanced synovial sarcomas: a multicenter retrospective study from four European institutions and the Italian Rare Cancer Network

Sanfilippo, Roberta; Dileo, Palma; Blay, Jean-Yves; More

Anti-Cancer Drugs . 26(6):678-681, July 2015.

  • Open Access

Sodium meta-arsenite induces reactive oxygen species-dependent apoptosis, necrosis, and autophagy in both androgen-sensitive and androgen-insensitive prostate cancer cells

Kim, Yunlim; Jeong, In Gab; You, Dalsan; More

Anti-Cancer Drugs . 25(1):53-62, January 2014.

Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival

Tahover, Esther; Segal, Amiel; Isacson, Rut; More

Anti-Cancer Drugs . 28(7):787-794, August 2017.

1 2 3 4 5